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Abstract 
Insomnia means difficulty in falling asleep and/or stays asleep. Insomnia commonly leads to daytime sleepiness, 
lethargy, and a general feeling of being unwell. The most common treatment of insomnia includes GABAA 
receptor positive allosteric modulators or Melatonin agonists. Our study aimed to evaluate the efficacy of 
Magnesium- melatonin-vitamin B complex supplement in the treatment of insomnia. The study included 60 
patients diagnosed with insomnia. The patients were randomly divided into study group (N = 30), and control 
group (N = 30), and study group was treated with Magnesium-melatonin-vitamin B complex (one dose contains 
175 mg liposomal magnesium oxide, 10 mg Vit B6, 16 μg vit B12, melatonin 1 mg, Extrafolate-S 600 μg) once a 
day 1 hour before sleep, during the 3 months. The severity of insomnia symptoms was measured by self-reported 
Athens insomnia scale (AIS), with a cut-off score by Soldatos (AIS score ≥ 6). Mean AIS score at zero points was 
14.93 ± 3.778 in the study group and 14.37 ± 4.081 in the control group (p = 0.476), indicating the compatibility of 
the groups, and both scores correspond to mild to moderate insomnia. Mean AIS score after 3 months of the 
Magnesium- melatonin- vitamin B complex supplementation was 10.50 ± 4.21 corresponding to mild insomnia, 
while median AIS score in the control group was 15.13 ± 3.76 which is referred to moderate insomnia, and 
difference among groups was significant (p = 0.000). Our founding’s indicating that 3 months of the Magnesium- 
melatonin-vitamin B complex supplementation has a beneficial effect in the treatment of insomnia regardless of 
cause. 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Insomnia is a sleep disorder with difficulties to 
fall asleep or stay asleep or both. It is the most 
common sleep disorder, according to the American 
Psychiatric Association (APA), with approximately 
30% of all adults and 6-10% of those who have 
severe symptoms diagnosed as insomnia disorder [1]. 
Diagnostic Criteria from the Diagnostic and 
Statistical Manual of Mental Disorders, 5th edition 
(DSM-5) include: 
- Difficulty in initialisation or maintaining sleep 
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or early-morning awakening that leads to low quantity 
or quality of sleep. 
- Sleep disturbance that leads to impairment 
in social, occupational, educational, academic, 
behavioural, or other important areas of functioning. 
- Patients experience this even with adequate 
opportunity to sleep, at least 3 nights per week, and 
for at least 3 months. 
- Insomnia is not explained by the presence of 
mental disorders or medical conditions and is not 
associated with another sleep disorder [2]. 
Pharmaceutical and nonpharmaceutical 
treatments are recognisable for insomnia. The 
American College of Physicians (ACP) advised 
cognitive-behavioural therapy (CBT) as a first-line 
treatment for chronic insomnia in adults. Sleep 
hygiene training (avoiding caffeine, exercise near 
bedtime, watching TV or surfing the internet from the 
bed) can help you change some of these disruptive 
behaviours [1]. 
Medications that have insomnia as an 
approved indication are:  
- Benzodiazepine receptor agonist (non-
selective GABA-A receptor positive allosteric 
modulator)-estazolam, eszopiclone, flunitrazepam, 
flurazepam, lormetazepam, nitrazepam, quazepam, 
temazepam, triazolam, zaleplon, zolpidem (alpha 1 
subunit selective benzodiazepine receptor agonist). 
- Norepinephrine and serotonin reuptake 
inhibitor and 5-HT2 receptor antagonistdoxepine in 
very low doses 3mg and 6mg for insomnia in the USA 
- H1 and D2 receptor antagonist 
promethazine 
- OR1 and OR2 receptor antagonist 
suvorexant 
- Mel1 and Mel2 receptor agonist ramelteon 
and melatonin [3]. 
The hormone melatonin is produced during 
the sleep cycle. Studies are inconclusive regarding 
whether melatonin can help treat insomnia in adults, 
but melatonin could promote sleep by helping to 
regulate the body’s bio clock and sleep-wake cycles 
and to adhere to more healthful sleep patterns. 
Research indicates that melatonin may shorten the 
time it takes to fall asleep, increase overall sleep 
amounts, and may increase REM sleep [4], [5], [6]. 
Few sleep-promoting nutrients enhance sleep 
and relaxation. Magnesium is a muscle relaxant and 
inducer of the deeper sleep. Circadian rhythms 
dysregulation and compromised lifestyle also increase 
magnesium excretion, leading to deficiency [7]. 
Magnesium supplementation improves sleep 
efficiency, sleep time and sleep onset latency, early 
morning awakening, and insomnia objective measures 
such as the concentration of serum renin, melatonin, 
and serum cortisol, in older adults [8]. Dietary 
magnesium intake may have long-term benefits in 
reducing the likelihood of daytime falling asleep in 
women [9]. Anxiety can cause insomnia, and vice 
versa which can result in a self-perpetuating cycle, 
which leads to chronic insomnia. According to 
Australia’s Sleep Health Foundation, anxiety and 
worrying are leading causes of insomnia [1]. Existing 
evidence is suggestive of a beneficial effect of Mg on 
subjective anxiety in anxiety vulnerable samples, and 
for mild-to-moderate depression in adults within 2 
weeks [10], [11]. According to the National Sleep 
Foundation, insomnia promotes depression and 
depression-induced insomnia. A meta-analysis of 34 
studies concluded that insomnia is significantly 
associated with an increased risk of depression, which 
has implications for the prevention of depression in 
non-depressed individuals with insomnia symptoms 
[12]. Melatonin and the nonselective MT1 / 
MT2 receptor agonist agomelatine have displayed 
anxiolytic-like action and have been used in the 
elderly, but exact mechanisms of action are still 
unknown [13], [14]. Recent studies suggest that the 
MT2 receptor is implicated in the antidepressant-like 
effects of melatonin [15], [16]. 
The recent results showed mixed effects of 
vitamin B12 on sleep patterns [17] and promoting an 
effect of vitamin B6 on the reduction of psychological 
distress, which could induce sleep disturbance [18]. 
Contrary to that, there is clear evidence on the 
antidepressant effect of vitamin B12 [19] and vitamin 
B6 for therapy of hormone-related depression in 
women [20]. 
Our study aimed to evaluate the efficacy of 
Magnesium-melatonin-vitamin B complex supplement 
in the treatment of insomnia. 
 
 
Material and Methods 
 
The study included 60 patients diagnosed 
with insomnia who refused to take drugs for insomnia 
and have a positive attitude towards the supplements. 
The patients were randomly divided (bias coin 
randomization) into study group (N = 30), and control 
group (N = 30), and study group was treated with 
Magnesium-melatonin-vitamin B complex (one dose 
contains175 mg liposomal magnesium oxide, 10 mg 
Vit B6, 16 μg vit B12, melatonin 1mg, Extrafolate-S 
600 μg) once a day 1 hour before sleep, during the 3 
months. The manufacturer advertises it as mild rapid-
acting natural sleep medicine containing magnesium, 
melatonin, and vitamin B complex. It is recommended 
to use one capsule daily, evening dose, an hour 
before sleep. We followed the manufacturer’s 
recommendation regarding the supplement intake. 
The severity of insomnia symptoms was measured by 
self-reported Athens insomnia scale (AIS), with 
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Gamma-aminobutyric off score by Soldatos (AIS 
score ≥ 6). The severity of insomnia measured by AIS 
was graded according to Morin’s criteria: AIS score 7-
14- mild insomnia; AIS score 15-21- moderate 
insomnia; AIS score 22-28- severe insomnia. AIS and 
CGI-S scores were evaluated at zero points and after 
3 months of supplement consumption. 
 
Statistical analysis 
All collected data were analysed using the 
IBM SPSS Statistics for Windows (IBM SPSS, IBM 
Corp., Armonk, NY, USA) software, version 22.0. The 
descriptive statistics are presented as a central 
tendency (means) and variability (standard deviation 
and variation interval). Means were compared with the 
independent samples t-test, while for testing data of 
different categories, we used Pearson’s χ
2
 test and 
Mann-Whitney test. We used repeated-measures 
analysis of covariance (RM ANCOVA) for the 
assessment on t0 and t90 between and within the 
groups. The level of statistical significance was set at 
p < 0.05. 
 
 
Results 
 
Gender distribution was 67% male and 33% 
female in the study group and 77% male and 23% 
female in the control group. The average age in the 
study group was 51.40 ± 14.61 years, and 44.93 ± 
14.40 years in the control group, the age distribution 
of subjects indicating the comparability of the studied 
groups (p = 0.090). Mean AIS score at zero points 
was 14.93 ± 3.778 in the study group and 14.37 ± 
4.081 in the control group (p = 0.476), indicating the 
compatibility of the groups, and both scores 
correspond to mild to moderate insomnia. Mean AIS 
score after 3 months of the Magnesium-melatonin-
vitamin B complex supplementation was 10.50 ± 4.21, 
corresponding to mild insomnia, while the median AIS 
score in the control group was 15.13 ± 3.76 which 
refers to moderate insomnia, and difference among 
groups was significant (p = 0.000) (Table 1). 
Table 1: AIS score at zero and endpoint 
 T0 T90  
X ± SD; Med 
(min-max) 
p* X ± SD; Med 
(min-max) 
p* p** 
Study group 
14.93 ± 3.78; 15 
(9-24) 
 
0.476 
10.50 ± 4.21; 9 
(3-20) 
 
0.000 
 
0.000 
Control group 
14.37 ± 4.08; 
13.5 (9-24) 
15.13 ± 3.76; 14 
(10-24) 
*Mann-Whitney test; **Wilcoxon test. 
 
Mean CGI-S at zero point was 3.57 ± 0.568 in 
study group, and 3.43 ± 0.58 in control group (p = 
0.328). Difference become significant at the end point 
visit (p = 0.05) with mean CGI-S score 2.97 ± 0.77 in 
the study group, and 3.53 ± 0.63 in control group 
(Table 2). 
Table 2: CGI-S at zero and endpoint 
 T0 T90  
X ± SD; Med (min - max) p* X ± SD; Med (min - max) p* p** 
Study group 3.57 ± 0.57; 4 (3-5)  
0.328 
2.97 ± 0.77; 3 (1-4)  
0.005 
 
0.005 Control group 3.43 ± 0.57; 3 (3-5) 3.53 ± 0.63; 3 (3-5) 
 
*Mann-Whitney test; **Wilcoxon test. 
 
Mean CGI-I score after 3 months was 3.23 ± 
0.73 (minimally improved), which is significantly 
different in comparison with mean CGI-I score in 
control group 4.07 ± 0.25 (no change) (p = 0.000) 
(Table 3). 
Table 3: CGI-I at the endpoint 
 T90 
X ± SD; Med (min - max) p* 
Study group 3.23 ± 0.73; 3 (2-4)  
0.000 Control group 4.07 ± 0.25; 4 (4-5) 
*Mann-Whitney test. 
 
 
Discussion 
 
The results of this study demonstrate that 
supplementation with Magnesium-melatonin-vitamin B 
complex for 3 months has a significant positive effect 
on sleep disturbances and is highly effective for the 
treatment of patients with insomnia. Regardless of the 
insomnia aetiology, Magnesium-melatonin-vitamin B 
complex supplementation reduces insomnia 
symptoms, as well as its consequences, thus 
improving the patients’ quality of life and preventing 
potential unwanted clinical, social, economic, or 
emotional repercussions.  
Magnesium is one of the most important 
minerals in the human body. It is involved in more 
than 300 enzyme systems responsible for the 
maintenance of normal homeostasis [9]. One of the 
more recently discovered functions of magnesium is 
its effect on cellular timekeeping and regulation of 
circadian rhythm. Studies that back up this theory 
have shown that inadequately low levels of serum 
magnesium are associated with low quality sleep and 
insomnia [17]. Lack of magnesium intake seems to be 
involved in the development of depression, which 
increases the risk of insomnia [12]. 
A study performed by Abbasi et al. [8] 
examined the independent role of magnesium in the 
treatment of insomnia. After 8 weeks of magnesium 
supplementation, the patients had increased sleep 
time, as well as sleep efficiency. The results 
demonstrate that magnesium supplementation brings 
significant improvement, both subjective and 
objective, to the patients who have insomnia. These 
results are consistent with the results of our study, 
which demonstrates that magnesium, isolated or as a 
part of a combination supplement, is successful in 
treating insomnia. Interestingly, a statistically 
significant increase in serum melatonin concentration 
was recorded in the experimental group that received 
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dietary magnesium supplementation compared to the 
placebo group. This finding suggests the complicated 
interaction between these two elements that are both 
important for the regulation of sleep and the day-night 
cycle. 
Melatonin is a hormone produced and 
secreted by the pineal gland. It has an important role 
in the maintenance of the organism circadian rhythm, 
which is being expressed through a wide range of 
different physiologic, neuroendocrine, and behavioural 
functions. Its plasma concentrations reach a peak 
during nighttime, while during the daytime, they are 
barely measurable [15]. Animal and human studies 
have demonstrated that melatonin binds to the 
receptors in the central nervous system, producing an 
effect on sleep promotion and sleeping phase shifts 
[13], [16].  
Pharmacological agents that are prescribed 
for insomnia cannot reproduce the properties of 
physiological sleep and are associated with adverse 
effects like sedation, anxiety, tremor, tolerance to the 
drug or dependence [13]. The research conducted by 
Ochoa-Sanchez et al., [21] revealed that melatonin 
receptor agonists had much more favourable 
pharmacological properties in terms of sleep 
promotion and regulation when compared to 
prescribed benzodiazepines. Also, melatonin and its 
agonists did not produce adverse effects commonly 
attributable to benzodiazepines. 
The study of Grima et al. [5], which dealt with 
melatonin administration for sleep disturbances after 
traumatic brain injury, reported a significant 
improvement in sleep quality and sleep efficiency, as 
well as a reduction in fatigue and anxiety symptoms, 
after only 4 weeks of melatonin treatment. This result 
is consistent with our study, although patients in our 
experimental group did not receive isolated melatonin, 
as a part of the Magnesium-melatonin-vitamin B 
complex supplement, and they received it for a 
substantially longer period as well.  
From the B vitamins group, the best examined 
in terms of sleeping interactions is vitamin B12. The 
direct relationship between insomnia and vitamin B12 
levels is yet to be established. However, vitamin B12 
deficiency is known to be involved in the 
pathophysiology of depression, which can commonly 
be associated with insomnia [19].  
Lichstein et al. [18] examined the influence of 
different vitamin supplementation on sleep quality and 
duration. The results suggest that the use of 
combined multivitamin supplements, as well as single 
vitamins, including vitamin B complex, hurts sleep 
maintenance, causes a higher rate of insomnia, and 
requires greater use of sleep medicine. In contrast to 
this study, our results show that vitamin B complex, in 
combination with magnesium and melatonin, has a 
positive effect on sleep regulation and can be used to 
treat insomnia. This could be attributed to the 
combined additive effect of the three components of 
the prescribed supplement, in contrast to the single 
effects of isolated molecules that were previously 
tested. 
Although there are studies that investigated 
the effect of different combined supplements for the 
treatment of insomnia, to the best of our knowledge, 
this is the first study that investigated the particular 
combination of Magnesium-melatonin-vitamin B 
complex supplement. The research conducted by 
Rondanelli et al. [22] investigated the influence of the 
supplement consisting of melatonin, magnesium, and 
zinc on insomnia in the elderly. 
Their results showed that these elements 
were effective in managing sleep disorders after 2 
months of treatment. This finding is consistent with 
our study, which shows that common elements from 
both studies – magnesium, and melatonin have a 
significant effect on sleep regulation. 
Our findings indicate that 3 months of the 
Magnesium-melatonin-vitamin B complex 
supplementation has a beneficial effect in the 
treatment of insomnia regardless of cause. According 
to our results, Magnesium-melatonin-vitamin B 
complex augmentation improves AIS and CGI-S score 
with statistical significance relative to the control 
group. The global improvement according to the CGI-I 
score, was minimal but significant different compared 
with the control group where there was no change. 
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